All News
All news
-
News Trump and pharma execs to discuss progress on COVID-19 cure
The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure". -
News Packaging Toward a Sustainable Future
With the world’s attitude to tackling climate change arguably the global number one hot topic of 2019, the issue of sustainability is an emerging theme in pharmaceutical packaging. -
News FDA reports first coronavirus-related drug shortage
The US Food and Drug Administration has reported the first case of a pharmaceutical drug shortage directly related to the global coronavirus (COVID-19) outbreak that is threatening to reach pandemic status. -
News CPHI Japan 2020 Postponed
Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference. -
News Merck KGaA, AMCM/EOS co-operate in 3D printing of tablets
A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ... -
News BIA Separations signs agreement to commercialise novel elution technology
Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy. -
News WuXi Biologics and Vir Biotechnology announce mAbs development collaboration to treat COVID-19
Chinese CDMO WuXi Biologics has linked up with San Francisco biotech firm Vir Biotechnology to develop and manufacture human monoclonal antibodies (mAbs) to potentially treat coronavirus disease (COVID-19), the two firms said Tuesday. -
News Accomplished scientific leader and GSK veteran, Dean Edney joins Sai Life Sciences
Sai Life Sciences, today announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development. -
News Non-hormonal treatment for menopausal hot flashes begins clinical trials
The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life. -
News New Sartorius QbD tool supports faster Raman model building
Unlocking the potential of Raman spectroscopy as a high throughput analytical technique for monitoring cell culture in mini bioreactors. -
News CGT service providers link up to provide greater supply chain visibility
Cell and gene therapy service providers TrakCel and Ori Biotech have agreed a strategic partnership whereby TrakCel’s tracking software will be closely integrated with Ori’s automated platform to give users greater live supply chain visibility within c... -
News Dipharma builds cGMP manufacturing suite at US subsidiary
Italy’s Dipharma Francis has completed construction of a new cGMP manufacturing suite at its US subsidiary, Kalexsyn, strengthening its service offering and ensuring continuity across the product lifecycle from preclinical to commercialisation , the co... -
News Sanofi to create standalone European API production powerhouse
Sanofi's plans to create a European company to manufacture and market active pharmaceutical ingredients (APIs) should help to balance the region's heavy reliance on sourcing them from Asian markets, the French pharmaceutical firm said Monday. -
News Pipelines, Economics and IP: How Bioprocessing Tech Firms Assess Markets
Identifying areas of unmet need to guide R&D strategy and shape drug pipelines -
News Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD
Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase. -
News ScentSational adds Hearts to its line of Aroma and Taste Enhancing ScentCerts for Pharmaceutical and Dietary Supplements
ScentSational Technologies has selected CPHI on May 5, 2020 at the Philadelphia Convention Center to enable attendees to experience the Company’s latest innovation in multi-sensory branding for Dietary Supplements. -
News Tufts CSDD Demonstrates Multi-Million Dollar Benefits of Translational Pharmaceutics®
Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lo... -
News The game is on for connected devices
The future of value-added medicines will see gamification transforming the engagement of therapies. -
News Recipharm expects cost synergies from Consort purchase within 18 months
Recipharm expects cost synergies of SEK 125 million (USD 12 million) from its recent acquisition of UK drug delivery firm Consort Medical and should realise them within the next 18 months, the Swedish contract research and development organisation (CDM... -
News Univercells' €50M investment to speed delivery of manufacturing tech
The investment will support continued expansion into the fast-growing gene therapy segment, including new developments that will enable a range of best-in-class solutions for viral manufacturing. -
News Patient-centric digital platform on Boehringer Ingelheim clinical trials launched
Boehringer Ingelheim and Carebox Healthcare Solutions have launched a digital platform to provide patients, caregivers and doctors with information on the German drugmaker’s clinical trials. -
News Wuxi Biologics subsidiary agrees 20-year manufacturing deal with global vaccine leader
A subsidiary of WuXi Biologics has signed a 20-year vaccine manufacturing contract worth around USD 3 billion with a global vaccine company, the Chinese contract development and manufacturing organisation (CDMO) said Tuesday. -
News Management healthcare consultancy opens new offices in New York and London
The expansion will enable Putnam Associates to access the European market and to offer more localised support to its clients. -
News Dr Reddy's to acquire Wockhardt divisions
Deal sees 62 brands in multiple therapy areas and a manufacturing plant transfer to the company -
News Change of mindset from cost to value needed for smart pharma packaging: CPI
Pharmaceutical companies need to change their mindset and focus more on delivering extra value from smart packaging rather than reducing the cost of their packaging operation, according to Alex Cole, senior strategic marketing manager at CPI. -
News Sphere Fluidics expands to increase supply of surfactant for droplet microfluidics
Investment in resources to meet demand for large-scale supply of patented biocompatible surfactant. -
News CPHI South East Asia rescheduled for July 2020
Event move ensures extra precautions and safety measures taken -
News Acino Contract Manufacturing agrees strategic partnership with Quay Pharma
Acino Contract Manufacturing is pleased to announce a strategic partnership with UK-based Quay Pharma for the formulation and development of manufacturing processes for Oral Solid Dosage forms. The partnership will see both companies provide respective... -
News Behaviour design should be lynchpin of digital health strategy, says Roche executive
Developers of digital health tools designed to improve adherence to medicines need to make behavioural science the cornerstone of their strategy if they are to keep patients engaged and motivated, according to Paul Upham, Head of Smart Devices at Roche... -
News Sartorius sharpens its brand focus
The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster. -
News Gene Therapy: A Complex and Evolving Manufacturing Challenge
Gene therapies have the potential to revolutionize treatment options for patients suffering from cancer, cystic fibrosis, heart disease, diabetes, Parkinson's, AIDS and Alzheimer's by replacing, inactivating or introducing genes into cells &mda... -
News FDA success for MedPharm Centre of Excellence
The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product. -
News Report predicts booming ASEAN generics export market for 2020
The changing opportunities are attributed to rising GMP standards and increased regional harmonization. -
News EuTech announces new management team additions
EuTech has recently added two strong professionals in its Management Team. Shekhar Yerramilli has joined as COO and Rick Yglesias has joined as Head of Business Development. -
News Partnership formed to deliver effective biopharma industry testing
Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols. -
News ReForm and MilliporeSigma agree excipient development and commercialization deal
Merck KGaA’s US life science arm, MilliporeSigma, has signed a global licence agreement with biologics technology firm ReForm Biologics to commercialize the latter’s proprietary excipients used in biotherapeutic formulations. -
News PCI Pharma Services announces Bellwyck acquisition
PCI Pharma Services has bought Toronto-based packaging and labelling specialist Bellwyck Pharma Services, adding four GMP-compliant facilities in the US, Germany and Canada to its global network, the CDMO announced Tuesday. -
News CDMO Revenues Reflect Bio Outsourcing Surge
Biopharmaceutical outsourcing has increased markedly in recent years with a greater volume of work previously kept in-house being handed over to third party contractors -
News Innovation awarded at Pharmapack
Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design. -
News Lonza to invest CHF 12 million in CO2 reduction at Visp facility
Lonza will invest CHF 12 million (USD 12.3 million) in a catalytic convertor at its Visp manufacturing site to reduce annual emissions of carbon dioxide by 600,000 tons or 98%, the Switzerland-based contract development and manufacturing organisation (... -
News Cost and volume pressures giving rise to value-added medicines: IQVIA
Rising pharmaceutical cost pressures and volume growth deceleration are forcing pharmaceutical companies to attempt to extract further value from existing medicines rather than solely pursuing new molecules, according to Aurelio Arias, Engagement Manag... -
News 2020 - a year for 'big answers' rather than 'big data'
Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond. -
News Recipharm acquisition to make it a top 5 global CDMO?
CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company. -
News New Velesco Pharma clinical manufacturing facility begins operations
The facility will triple the company’s cGMP clinical trial manufacturing capacity. -
News Hovione announces key patent grants for its large dose DPI
TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles. -
News Colorcon starts No-Tox ink manufacturing at new UK facility
The additional capacity will provide customers with shorter lead times and reduced transportation costs. -
News Vetter aligns development service laboratory portfolio under one roof
Bundling of competencies optimizes workflow of customer projects. -
News Delpharm and the Famar Group announce the acquisition by Delpharm of 5 manufacturing sites in France, Canada and the Netherlands.
Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), ... -
News US Pharma Outlook: Ten Trends to Look Out For in 2020
With CPHI North America fast approaching, we asked several industry experts what they see as the main trends emerging across the US pharma supply chain this year. -
News Thinking Outside the Box, What's Driving R&D in Pharma Packaging?
Evolving patient needs, growing demand for traceability and increasing cost pressures have awakened innovation in the pharmaceutical packaging sector. -
News FDA approves only triple-combination tablet with Jardiance
Trijardy XR is a once-daily therapy combining three well-established treatments in one pill. -
News Sai Life Sciences to recruit 300+ scientists for its upcoming research facility
Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemist... -
News OCD drug candidate created by AI ready for clinical trials in record time
A new drug candidate has been created by artificial intelligence (AI) for the very first time, with the exploratory research route to phase I clinical trials taking less than 12 months, considerably shorter than the typical four and a half years using ... -
News CDMO WuXi Biologics says drug supply unaffected by coronavirus
Amid heightened global concern over the recent coronavirus outbreak, Chinese CDMO WuXi Biologics has sought to reassure customers and patients that its drug supply lines have been unaffected. -
News ALPLApharma – a new global provider of innovative pharmaceutical packaging
ALPLApharma, a new brand of the global packaging specialist ALPLA Group, will introduce itself for the first time to industry professionals at the CPHI Worldwide exhibition. -
News Inovio and Beijing Advaccine to advance vaccine against Coronavirus
Agreement will facilitate clinical trial translations in China. -
News Dr Reddy’s receives five FDA observations on Srikakulam API plant
The US Food and Drug Administration has issued India’s Dr Reddy’s Laboratories with five observations after a recent inspection at its active pharmaceutical ingredient (API) manufacturing plant at Srikakulam. -
News Digital value-added medicines - a key driver for 2020
Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead. -
News Merck KGaA invests Eur250 million in Swiss manufacturing and R&D facility
German company Merck KGaA is investing Euro 250 million in a Swiss biologics facility that bridges manufacturing and research. -
News Careers in Chemical Manufacturing: From benchtop chemistry to the installation of bespoke manufacturing technology
As manufacturing industries continue to promote the diverse roles available in science, technology, engineering and mathematics (STEM) disciplines, we turn the spotlight on careers in chemical manufacturing…
-
News Nabis and Panaxia form JV to launch pharma grade cannabis products in Arizona
Canadian investment firm Nabis Holdings said Tuesday it has agreed to form a joint venture with Israeli pharmaceutical company Panaxia to launch a range of cannabis-based pharmaceutical products in the US state of Arizona in the second half of 2020. -
News Cognate completes purchase of advanced therapy CDMO Cobra
Cognate BioServices, a contract development and manufacturing organization specialising in cell and gene therapy, has completed its purchase of Cobra Biologics, a CDMO specialized in providing development and manufacturing services for plasmid DNA and ... -
News CNS completes API pilot manufacturing to take Berubicin closer to clinical trials
Biotech firm CNS Pharmaceuticals said Tuesday it has completed pilot manufacturing of a key active pharmaceutical ingredient for its brain tumor drug Berubicin, taking it closer to clinical trials. -
News First human trial of monoclonal antibody to prevent malaria opens
If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common. -
News Piramal to expand Aurora facility with API manufacturing wing
Indian CDMO Piramal Pharma Solutions said Tuesday it will invest C$25 million to expand the capacity of its Aurora facility in Canada by 10,500 square feet to house a new wing for manufacturing active pharmaceutical ingredients (APIs). -
News Merck invests in biotech development facility in Switzerland
€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing. -
News AstraZeneca embarks on $1bn zero carbon strategy
The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants. -
News AstraZeneca commits to near-zero GWP asthma inhalers by 2025
UK pharmaceutical firm AstraZeneca has committed to launching its next-generation asthma and chronic pulmonary disease inhaler with near-zero carbon propellants by 2025. -
News YC4PV presents vaccine awareness manifesto to European Commission
A manifesto making recommendations on how to improve the uptake of vaccines and raise awareness of immunization among European has been presented to the European Commission. -
News Lilly to build new manufacturing facility and create 460 new jobs
The $470 million investment will support a state-of-the-art facility that produces injectable products and delivery devices. -
News In the know: New ISO standard published for footwear manufacturing
The International Organization for Standardization (ISO) has published a new standard, named ISO 19577:2019 Critical substances potentially present in footwear and footwear components -- Determination of Nitrosamines. -
News Diabetes diagnosis - now a matter of sweat and tears?
No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy. -
News Grey Wolf Therapeutics secures funding for cancer therapies development
The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. -
News Quality laboratory data with PPD Laboratories
Quality laboratory data is vital to your pharmaceutical development program. -
News Meet Sai Life Sciences at CPHI, Japan 2020
Sai Life Sciences will be in Tokyo for CPHI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email [email protected]. -
News Skyepharma set-up for serialization and aggregation, ready for Russian market
Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation. -
News CURE sees delivery platform as springboard for success
In this exclusive interview, CURE Pharmaceutical COO Jessica Rousset explains her company’s dual pharmaceutical/nutraceutical approach and why the cannabinoid space is ripe for drug delivery innovation -
News Forté Pharma strengthens cosmetics range with oral supplement launch
Reig Jofre's oral, anti-wrinkle, moisturizing and firming cosmetic expands Forté Pharma's beauty range. -
News Lonza set to sell two lipid oral dosage forms sites to NextPharma
The potential acquisition will see UK CDMO NextPharma develop and broaden its technology offering into lipid-based finished dosage forms -
News Wuxi to acquire Bayer final drug product manufacturing site
First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities. -
News Former Bosch drug packaging division renamed Syntegon
Business to focus on intelligent and sustainable technologies. -
News BioMarin gets go-ahead to start gene therapy clinical trials
BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program. -
News GHO Capital acquires Ardena
GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma -
News French regulator agrees to partial resumption of Tellomak trial patient recruitment
The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ... -
News Biogen to acquire novel clinical-stage asset from Pfizer
PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases. -
News Catalent launches direct-to-patient clinical supply services
Multiple options provide increased flexibility for sponsors. -
News Intensification and Consistency: Driving Biomanufacturing Innovation
Biopharma’s desire for fast, cheap production and cell and gene therapy firms’ need for consistency is shaping tech development in the sector. -
News Partnership formed to develop and commercialise ready-to-use medicine
The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products. -
News Lupin could face FDA regulatory action over Tarapur API facility
India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility. -
News Dr. Mark Bittinger joins Sai Life Sciences as Global Head of Biology
Dr. Mark Bittinger has joined Sai Life Sciences as Vice President and Global Head of Biology. Mark will be based out of companys' new Discovery Biology facility in Cambridge, Massachusetts, USA, which provides exploratory biology capabilities to the... -
News Jay Stella joins Sai Life Sciences as Chief Business Officer
Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for t... -
News CPHI and AAPS partner to expand expert scientific content at CPHI North America
CPHI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPHI, including CPHI North America—the only event to bring the entire North American pharmac... -
News ReadCoor to commercially launch spatial sequencing platform
Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine. -
News Mylan recalls batches of Nizatidine capsules after nitrosamine detected in API
The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination. -
News BONA Service: Spray performance analysis per FDA guidance
Includes:
* Spray pattern
* Plume geometry
* Droplet size distribution
Other tests:
* Priming and Repriming
* Dosage
* Dose uniformity -
News New HQ for developer of world's first fully automated drug discovery platform
End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data. -
News VAV Life Sciences launches India’s first phospholipid manufacturing plant
VAV Life Sciences has inaugurated its cGMP compliant phospholipid manufacturing plant in Mirjole, Ratnagiri, Maharashtra. -
News WuXi STA opens large-scale oligonucleotide manufacturing facility
Expands company's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial. -
News Boxing clever: Smart packs improving communication with patients
Drug industry expectations of packaging are evolving with developers now seeking techs that help patients get more from their medicines. -
News NIH researchers discover new autoinflammatory disease
Mutations in the RIPK1 gene responsible for CRIA syndrome. -
News UCB to build new biotech manufacturing plant in Belgium
Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches. -
News BioAscent scientists help identify potential new treatments for cancer
Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. -
News Astellas strengthens immuno-oncology pipeline with acquisition of Xyphos Biosciences
Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapy. -
News Botox still looking good on 30th anniversary
Botox and Botox Cosmetic (onabotulinumtoxinA) hold 14 therapeutic and aesthetic indications combined, more than any other neurotoxin in the world. -
News Colorcon launches on-dose authentication technology platform
Next-generation pharmaceutical supply-chain security for tracking product from plant to patient. -
News Sartorius tests and develops AI in its products and platforms
Customers and partners look set to benefit from reduced development times and costs of medical drugs. -
News Pharma Outlook: 10 Trends to Look Out For in 2020
We asked ten industry experts for their thoughts on some of the emerging trends for the pharmaceutical supply chain as the industry enters 2020... -
News Colorcon expands manufacturing and completes renovation of North America campus
The investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products. -
News Innovation and regulatory harmonisation to drive Indian pharma in 2020
Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports. -
News 'Niche' CMO invests in UK facility to expand viral vector sterile manufacturing
CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020. -
News 2019, the year that got serialization done!
The past 12 months have been busy as many companies fought to comply with serialization regulations. -
News Sanner introduces bio-based plastic packaging
Represents the first biopackaging of its kind made of renewable raw materials. -
News "The surge continues in pharmaceutical services” – C&EN report features Sai Life Sciences
The Chemical & Engineering News, arguably the world's most comprehensive and authoritative news source about chemistry and related fields, featured Sai Life Sciences in its report covering CPHI Worldwide 2019. -
News Sai Life Sciences announces Sai Nxt, an initiative to transform the organization into a new generation CDMO
Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced Sai Nxt, an organization-wide initiative aimed at transforming the company into a new generation CDMO. -
News NIH launches first US clinical trial of patient-derived stem cell therapy to replace dying cells in retina
NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment. -
News Smarter clinical trial supply planning
New CTSuccess service helps to reduce the risk of delays and budget overspend. -
News Catalent helps to advance new opioid addiction treatment
The fast-dispersing Zydis formulation could increase compliance with Medication-Assisted Treatment and thus better clinical outcomes. -
News Edible barcodes - it's Tru!
Smart tags on pills set to improve supply chain security and patient adherence. -
News US Pharmaceutical industry continues to shine according to CPHI 2019 Annual Report
The US pharmaceutical industry continues to lead its global peers in terms of innovation and competitiveness, while still ranking high in overall growth potential despite its mature status, according to the results of a survey of 350 global pharmaceuti... -
News Recipharm investment strengthens its inhalation development service
Installation of a SprayVIEW system will help the CDMO to support customers in both innovative and generic inhalation and nasal product development.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance